Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review

Jie Fu,Yuchen Liu,Houwen Lin,Bin Wu
DOI: https://doi.org/10.1007/s40261-018-0706-5
2018-01-01
Clinical Drug Investigation
Abstract:The objective of this systematic review was to conduct a comprehensive assessment of economic evaluations of tyrosine kinase inhibitors (TKIs) in patients with chronic myeloid leukemia (CML) in middle- and high-income countries.
What problem does this paper attempt to address?